LFA
IART icon

Legacy Financial Advisors’s Integra LifeSciences IART Stock Holding History

Legacy Financial Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-736
Closed -$41K – 468
2019
Q1 		$41K Hold
736
– – 0.01% 307
2018
Q4 		$33K Buy
+736
New +$40.4K 0.01% 315

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Legacy Financial Advisors's IART Position: Q2 2019 in Review

Legacy Financial Advisors sold out of Integra LifeSciences (IART) in Q2 2019, closing a stake of 736 shares — an estimated $41K sold.

Legacy Financial Advisors first reported a position in IART in Q4 2018 and held it in 2 quarters. The position peaked at $41K in Q1 2019. 262 funds tracked by Wall St. Rank hold IART as of Q2 2019.

  • Legacy Financial Advisors reported no remaining Integra LifeSciences position as of Q2 2019 after selling out during the quarter.
  • Legacy Financial Advisors sold 736 Integra LifeSciences shares in Q2 2019, an estimated $41K.
  • Legacy Financial Advisors first reported a position in Integra LifeSciences in Q4 2018 and held it in 2 quarters.
  • Legacy Financial Advisors's Integra LifeSciences position peaked at $41K in Q1 2019.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2019.

Based on Legacy Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.